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This study compared the effects of varying lipid content and dietary concentration of a lipid-encapsulated (LE)
ZnO product to those of native ZnO and thereby to find insights into optimal lipid coating and dosage of the Zn
supplement. A total of 192 21-d-old weanling pigs were allotted to 48 pens, after which each six pens received a
ZnO-free basal diet supplemented with 125 ppm ZnO (100 ppm Zn; BASAL), 2,500 ppm Zn as native ZnO (HIGH),
or 100 or 200 ppm Zn as LE ZnO (LE-100 or LE-250) containing 8%, 10%, or 12% lipid [LE-8%, LE-10%, or LE-12%,
respectively; 2 × 3 factorial arrangement within the LE-ZnO diets (LE-ALL)] for 14 d. Forty pigs were killed at the end
for histological and biochemical examinations. None of ADG, ADFI, gain:feed, and fecal consistency score differed
between the LE-ALL and either of the BASAL and HIGH groups. Hepatic and serum Zn concentrations were greater
(p <0.05) in the HIGH vs. LE-ALL group, but did not differ between LE-ALL and BASAL, between LE-100 and -250, or
among LE-8%, -10%, and -12% groups. Villus height (VH), crypt depth (CD), and the VH:CD ratio in the duodenum,
jejunum, and ileum did not differ between the LE-ALL and either of the BASAL and HIGH groups, except for a
greater CD in the duodenum in the LE-ALL vs. HIGH group. Additionally, VH and CD in the duodenum and VH:CD
in the jejunum were greater in the LE-250 vs. LE-100 group. Specific activities of sucrase, maltase, and leucine
aminopeptidase in these intestinal regions and those of amylase and trypsin in the pancreas were not influenced
by the lipid content or dietary concentration of LE ZnO and also did not differ between the LE-ALL and either
of the BASAL and HIGH groups, except for a greater pancreatic amylase activity in the former vs. HIGH group. In
conclusion, the present results indicate that the LE ZnO, regardless of its lipid percentage or supplementation level
examined in this study, has no significant effect on growth performance, fecal consistency, or digestive enzyme
activities of weanling pigs under the experimental conditions.
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Zinc oxide (ZnO) is commonly supplemented to the pig
starter diet to 2,000 to 3,000 ppm to prevent the post-
weaning diarrhea as well as to enhance transiently retarded
growth of post-weaning pigs [1-3]. However, supplementa-
tion of ZnO at this pharmacological level poses substantial
concerns about environmental pollution, because dietary* Correspondence: cylee@gntech.ac.kr
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unless otherwise stated.ZnO is mostly unabsorbed and therefore excreted into the
environment via feces [4,5]. This has led to limiting the
in-feed ZnO concentration within 150 ppm by legislation
in the European Union. Accordingly, some manufacturers
have lately introduced new ZnO products which are more
active or more efficiently delivered to the intestine than
conventionally used ZnO, thereby suggesting the possibil-
ity of reducing the amount of ZnO added to the diet by
substitution of the former for the latter.
A few types of non-covalent ZnO-carrier conjugates
have been manufactured as a means of increasing thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,




Crude protein (%) 16.50
Ether extract (%) 3.91
Lysine (%) 1.21
Zn (ppm) 100, 250, or 2,500
1)The composition of ingredients, which was grains-soy-whey-based, was reported
previously [11]. Experimental diets were manufactured by supplementing the basal
diet containing no Zn additive with 125 or 3,125 ppm of native ZnO or 139 to
355 ppm of Shield Zn® (CTCBIO, Seoul) encapsulated with 8%, 10%, or 12% lipid
(w/w) to provide 100, 250, or 2,500 ppm of Zn.
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have reported that 600 to 900 ppm supplementation of
Zn as ZnO supported on zeolite or 500 ppm of Zn as a
ZnO-smectite conjugate was as effective as 2,000 to
2,250 ppm of Zn as native ZnO in enhancing growth
performance and digestive function of weanling pigs.
HiZox (Animine, France) is also a ZnO product whose
surface area is maximized to increase the bioavailability
of the compound. As for its relative potency, Morales
et al. [9] have reported that post-weaning pigs fed a diet
supplemented with 110 ppm of Zn as HiZox exhibited
a greater ADG, a greater G:F ratio, and a better health
status than those fed the same diet supplemented with
2,500 ppm of Zn as ZnO; however, this needs to be
confirmed.
The ZnO particle has also been coated with an enteric
substance to increase the delivery of the mineral to the
intestine [10-12]. Shield Zn (CTCBIO, Inc., Seoul) is a
lipid-encapsulated ZnO product, which has been manu-
factured based on a rationale that the encapsulated ZnO
particle reaches the intestine efficiently and is subse-
quently released upon digestion of the lipid capsule by
lipase because unlike the inorganic ZnO, the mineral
component of the product is not released as Zn2+ under
acidic pH in the stomach owing to the outer enteric
coating [12]. In this connection, we have found that diet-
ary supplementation of 72 ppm of Zn as the LE ZnO
(100 ppm) was as effective as 2,000 ppm of Zn as native
ZnO (2,500 ppm) in alleviating reduced growth, diarrhea,
and impaired integrity of intestinal mucosal structure in
weanling pigs artificially infected with enterotoxigenic
Escherichia coli (ETEC) K88 [11]. The present study was
undertaken to investigate the effects of the LE ZnO rela-
tive to those of native ZnO as well as the effects of the
lipid content and dietary concentration of the LE ZnO on
growth and the measures of digestive function as an initial
step to finding the optimal lipid coating and dosage of the
Zn supplement in naïve weanling pigs.
Methods
Animals
The protocol for the present experiment was approved
by the Institutional Animal Care and Use Committee
(IACUC) of Gyeongnam National University of Science
and Technology. The (Yorkshire × Landrace) × Duroc pig-
lets were divided into the high-, medium- and low-body
weight categories at weaning at 21 days of age. Ninety-six
high- and 96 medium-body weight weanling pigs were
randomly allotted to 48 pens by body weight to forty-eight
1-m2 nursery pens, with two females and two castrated
males housed per pen equipped with a feeder and a nipple
waterer. Each six pens received a ZnO-free basal nursery
diet supplemented with 125 ppm of native ZnO (100 ppm
ZnO; BASAL), 3,125 ppm of native ZnO (HIGH), 100 or200 ppm Zn as LE ZnO (LE-100 or LE-250) containing
8%, 10%, or 12% lipid [LE-8%, LE-10%, or LE-12%,
respectively; 2 × 3 factorial arrangement within the LE-
ZnO diets (LE-ALL)] for 14 d (Table 1). The basal diet
was formulated to contain a low percentage of crude pro-
tein to reduce the post-weaning diarrhea resulting from
undigested proteins [10,13]. The ambient temperature was
maintained at 30°C up to d 7 and then lowered to 29°C.
Fecal consistency was scored on d 1, 4, 7, and 14 accord-
ing to an arbitrary 3-point integer scale as described by
Heo et al. [13] and Zhao et al. [14]: 1, well-formed feces;
2, sloppy feces; 3, diarrhea.
Collection of blood samples and intestinal tissues
A total of 40 pigs, which consisted of 16 pigs from the
BASAL and HIGH groups (8 pigs each) and 24 pigs from
the 6 LE groups (4 pigs each), were sacrificed as described
previously [15]. Blood, pancreas, and intestinal tissues at
the regions of the duodenum, jejunum, and ileum were
collected also as described [11,15].
Determination of Zn
Five grams of hepatic tissue or 1 mL of serum was
digested with 10 mL of 70% nitric acid at 150°C to
complete solublization, filtered and diluted with 100 mL
of distilled water. The Zn content in the digested and
diluted solution was determined using an inductively
coupled plasma atomic emission spectrophotometer
(model 5300DV, Perkin-Elmer, Waltham, MA, USA).
Histological and biochemical determinations
The intestinal tissue was fixed, embedded in paraffin,
mounted on the glass slide, stained, and subjected to
microscopic determination of the villus height and crypt
depth as described previously [11,15].
The intestinal mucosa and pancreatic tissue were ho-
mogenized and stored at −70°C until used. The protein
content of the homogenate was determined using the
bicinchronic acid protein assay kit (Pierce, Rockford, IL,
USA); the specific activities of sucrase, maltase, leucine
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previously [15-17].
Statistical analysis
All data were analyzed using the MIXED procedure of
SAS (SAS Inst. Inc., Cary, NC, USA). The pen was the
experimental unit in all variables, except for postmortem
measurements in which the piglet was regarded as the
experimental unit. The model included each dietary
treatment as the main effect. In the analysis of repeated
measurements, effects of the day and its interaction with
the main effect were also included in the model. Accord-
ingly, effects of the diet and the day including its inter-
action with the diet were tested using the experimental
unit and experimental unit × day as error terms, respect-
ively. In addition, effects of supplementation of LE ZnO
vs. native ZnO as well as those of the lipid percentage
and supplementation level of LE ZnO were analyzed by
the contrast.
Results
Growth performance including the average daily gain
(ADG), average daily feed intake (ADFI), and gain:feed
(G:F) ratio during the 14-d experimental period did not
differ between the LE-ALL group and either of the
BASAL and HIGH groups (Table 2). Moreover, within
the LE-ALL group animals, the performance parameters
were not different between the LE-10% group and eitherTable 2 Effects of supplementations of native ZnO and lipid-e
consistency of weanling pigs1)
Variable Dietary supplementation (ppm
Native ZnO LE ZnO
100 2,500 8% lipid2) 10% lipid2) 12
100 250 100 250 10
Growth performance
Initial BW (kg) 6.69 6.98 6.76 6.67 6.71 6.65 6.7
Final BW (kg) 9.63 9.89 9.65 9.35 9.52 9.18 9.6
ADG (g) 210 207 207 192 201 180 208
ADFI (g) 355 367 355 329 344 327 348
G:F 0.591 0.569 0.582 0.586 0.581 0.538 0.60
Fecal consistency score3)
Day 1 1.00 1.00 1.00 1.00 1.00 1.00 1.0
Day 4 1.00 1.13 1.08 1.00 1.00 1.13 1.0
Day 7 1.04 1.00 1.04 1.00 1.04 1.13 1.1
Day 14 1.17 1.00 1.17 1.17 1.25 1.35 1.1
Overall4) 1.05 1.03 1.07 1.04 1.07 1.15 1.0
1)Data are means of 6 pens in each dietary group.
2)Denotes the percentage of lipid (w/w) encapsulating the ZnO particle.
3)Scored according to a 3-notch integer scale: 1, well formed; 2, sloppy; 3, diarrhea.
4)P-values for the day and day × treatment were <0.01 and 0.71, respectively.
aApplies to all day × treatment combinations.
BW, body weight; ADG, average daily gain; ADFI, average daily feed intake; G:F, gainof the LE-8% and LE-12% groups or between the LE-100
and LE-250 groups.
The majority of the piglets exhibited well-formed feces
throughout the experimental period, although the fecal
consistency score (FCS) was greater (P <0.01) on d 14
than at any other time point (Table 2). However, the
FCS did not differ between the LE-ALL group and either
of the LBASAL and HIGH groups, between the LE-10%
group and either of the LE-8% and -12% groups, or
between the LE-100 and -250 groups.
The Zn concentration in the liver did not differ between
the LE-ALL and BASAL groups (Table 3). However, hep-
atic ZnO concentration was 11-fold greater in the HIGH
vs. LE-ALL group whereas within the LE-ALL group, it
was not influenced by the lipid percentage or supplemen-
tation level of the LE ZnO. Serum Zn concentration,
which did not differ between the LE-ALL and BASAL
groups, was marginally greater in the HIGH group vs. LE-
ALL (2.45 vs. 1.49 μg/mL; P <0.01). However, within the
LE-ALL group, serum Zn concentration was not influ-
enced by the lipid percentage or supplementation level of
the ZnO product.
The villus height (VH) and crypt depth (CD) in the
LE-ALL group were not different from those in the
BASAL and HIGH groups in the duodenum (Table 3).
Within the LE-ALL group, these morphology variables
did not change due to a change in the lipid percentage
of the LE ZnO, but increased when the supplementationncapsulated ZnO (LE ZnO) on growth and fecal
as Zn) Contrast P-value
SEM
LE ZnO vs. Within LE ZnO
% lipid2) P-value Native ZnO 10% lipid vs. 100 vs.
2500 250 100 2,500 8% 12%
4 6.73 0.15 0.85 0.92 0.05 0.78 0.67 0.63
5 9.73 0.20 0.32 0.65 0.14 0.52 0.15 0.34
214 11 0.49 0.50 0.60 0.49 0.11 0.34
369 13 0.24 0.49 0.13 0.60 0.09 0.51





8 1.07 0.04 0.59 0.35 0.11 0.07 0.27 0.63
:feed.
Table 3 Effects of dietary supplementations of native ZnO and lipid-encapsulated ZnO (LE ZnO) on hepatic and
circulating Zn concentrations, intestinal villus structure, and specific activities of digestive enzymes in weanling pigs
Enzyme Dietary supplementation (ppm as Zn) Contrast P-value
Native ZnO1) LE ZnO
P-value
LE ZnO vs. Within LE ZnO
100 2,500 SEM 8% lipid2) 10% lipid2) 12% lipid2) SEM Native ZnO 10% lipid vs. 100 vs.
100 250 100 250 100 250 100 2,500 8% 12% 250
Zn concentration
Liver (μg/g) 34.9 412.1 13.6 33.3 55.4 27.8 33.5 36.3 39.0 19.2 <0.01 0.87 <0.01 0.48 0.72 0.52
Serum (μg/ml) 1.78 2.45 0.14 1.53 1.63 1.52 1.50 1.14 1.62 0.22 <0.01 0.10 <0.01 0.75 0.57 0.31
Villus structure
Duodenum
VH (μm) 292 284 14 299 365 299 315 277 323 20 0.07 0.21 0.10 0.22 0.71 <0.01
CD(μm) 230 227 11 240 282 238 276 231 256 16 0.07 0.07 0.05 0.78 0.41 <0.01
VH:CD 1.27 1.26 0.04 1.25 1.29 1.26 1.15 1.20 1.26 0.05 0.56 0.37 0.66 0.21 0.60 0.98
Jejunum
VH (μm) 280 252 16 254 315 240 266 275 263 21 0.31 0.54 0.38 0.15 0.46 0.17
CD(μm) 230 206 15 234 262 225 238 251 218 20 0.49 0.64 0.08 0.44 0.89 0.87
VH:CD 1.21 1.16 0.03 1.09 1.20 1.07 1.12 1.11 1.20 0.04 0.03 0.02 0.30 0.21 0.13 <0.01
Ileum
VH (μm) 245 209 13 215 247 245 234 230 232 19 0.56 0.48 0.11 0.67 0.67 0.62
CD(μm) 228 186 13 205 221 238 224 238 180 19 0.15 0.73 0.05 0.33 0.24 0.24
VH:CD 1.10 1.21 0.07 1.30 1.16 1.03 1.05 1.09 1.31 0.11 0.36 0.54 0.50 0.08 0.15 0.71
Enzyme activity (μmol end product · mg protein-1 · min-1)
Sucrase
Duodenum 0.043 0.034 0.008 0.076 0.039 0.040 0.049 0.041 0.044 0.012 0.25 0.61 0.14 0.26 0.89 0.39
Jejunum 0.874 0.537 0.225 0.319 0.401 0.160 0.628 0.509 0.170 0.318 0.59 0.06 0.51 0.91 0.86 0.79
Ileum 0.098 0.117 0.032 0.105 0.099 0.088 0.107 0.094 0.119 0.046 1.00 0.91 0.68 0.93 0.86 0.74
Maltase
Duodenum 5.18 4.41 1.10 8.15 4.56 5.98 7.71 5.34 7.80 1.56 0.36 0.28 0.10 0.76 0.86 0.88
Jejunum 15.87 12.70 3.48 8.35 12.95 10.28 14.10 13.88 5.38 4.92 0.76 0.22 0.64 0.76 0.61 0.99
Ileum 4.20 5.39 1.49 5.11 4.02 2.91 6.27 4.13 3.95 2.11 0.96 0.91 0.57 0.99 0.80 0.69
LAP
Duodenum 2.00 2.30 0.36 2.19 1.91 1.99 2.72 1.90 3.20 0.50 0.53 0.45 0.96 0.55 0.70 0.17
Jejunum 3.15 2.73 0.27 2.37 2.53 3.17 2.51 3.25 2.20 0.38 0.30 0.14 0.86 0.31 0.77 0.11
Ileum 1.76 1.93 0.29 2.04 1.71 1.68 1.94 1.61 1.81 0.41 0.99 0.90 0.69 0.88 0.81 0.89
Amylase (PAN) 241.2 142.1 23.0 262.1 185.1 224.3 240.7 237.6 231.4 31.4 0.06 0.67 <0.01 0.78 0.95 0.39
Trypsin (PAN) 0.156 0.107 0.022 0.149 0.127 0.150 0.184 0.160 0.197 0.032 0.43 0.86 0.06 0.37 0.71 0.53
1)Data are means of 8 animals in each group.
2)Denotes the percentage of lipid (w/w) encapsulating the ZnO particle. Data are means of 4 animals in each group.
VH, villus height; CD, crypt depth; LAP, leucine aminopeptidase; PAN, pancreas.
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(P <0.01). However, the VH:CD ratio in the duodenum
did not differ between the LE-ALL group and either of
the BASAL and HIGH groups, between the LE-10%
group and either of the LE-8% and -12% groups, or
between the LE-100 and -250 groups. In the jejunum,
the VH and CD did not differ between the LE-ALL
group and either of the BASAL and HIGH groups andalso were not influenced by the lipid percentage or sup-
plementation level of the LE ZnO. However, the VH:CD
ratio was greater (P <0.05) in the BASAL group (1.21)
than in the LE-ALL group (1.13), within which it was
greater (P <0.01) in the LE-250 vs. LE-100 group (1.17
vs. 1.09). In the ileum, the CD was greater in the LE-
ALL vs. HIGH group (218 vs. 186 μm); otherwise, the
villus morphology variables did not differ between the
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groups, between the LE-100 and -250 groups, or among
the LE-8%, -10%, and -12% groups.
Specific activities of sucrase, maltase, and leucine ami-
nopeptidase in the mucosa were not affected by any
treatment factor examined in the present study in any
intestinal segment (Table 3). Specific activities of amylase
and trypsin in the pancreas also did not change due to any
treatment factor, except for a greater amylase activity in
the LE-ALL vs. HIGH group.
Discussion
The present results indicated that neither supplementa-
tion level of native ZnO or LE ZnO nor lipid percentage
of the latter has any significant effect on ADG, ADFI, G:
F, or FCS. However, this does not necessarily mean that
neither pharmacological supplementation of native ZnO
nor the basal-level supplementation of LE ZnO has any
significant effect on these performance parameters, be-
cause even the known growth-enhancing effect of the
former [2,3,18,19] was not apparent under the present
experimental conditions. As a matter of fact, we have
observed a growth-enhancing effect of the LE ZnO sup-
plemented at a basal level (100 ppm as Zn concentra-
tion; unpublished results). The lack of growth-enhancing
effects of the LE ZnO and HIGH treatments in the
present study is therefore reflective of the known fact
that growth enhancers including ZnO are less effective
under experimental settings than under production con-
ditions [20,21]. In this context, the present results were
also reminiscent of the lack of effects of the in-feed anti-
biotics, the known growth enhancers in swine [20,21],
on growth performance of post-weaning pigs placed in
small experimental pens in our previous study [15]. As
such, more studies are warranted to determine the optimal
usage of the LE ZnO as a growth-enhancing dietary sup-
plement for weanling pigs under production conditions.
The several-fold and marginally greater Zn concentra-
tions in the HIGH vs. BASAL group in the liver and
serum, respectively, were consistent with published results
[22-24]. Moreover, neither circulating Zn concentration
was different between the LE ZnO and BASAL groups as
in a report of Kim et al. [10], nor hepatic Zn concentration
was influenced by the lipid coating. These results imply
that the supplementation level of ZnO is well reflected
into the Zn concentration in the liver where many heavy
metals are stored and that the absorption rate of Zn at the
intestine is not influenced by lipid coating of the ZnO
particle.
The lack of effect of the LE ZnO or HIGH treatment
on the intestinal villus structure was quite different from
the increase in the VH and/or VH:CD ratio as well as
the decrease in CD in response to either treatment in
weanling pigs artificially infected with ETEC K88 in ourprevious study [11]. Furthermore, the positive effect of
pharmacological ZnO on the integrity of the villus struc-
ture often observed in weanling pigs [25-27] also was
not apparent in the present study. These results are thus
interpreted to suggest that the beneficial effect of either
Zn supplement on the integrity of the villus may be
apparent only when the villus structure of the piglet is
substantially damaged by any causative like the microbial
infection. In this context, the increased VH in the duo-
denum and increased VH:CD in the jejunum in response
to the LE-250 treatment vs. LE-100 observed in the
present study, albeit intriguing, needs to be rigorously
confirmed to make any firm conclusion as to the dose
effect of the LE ZnO on the villus structure in naïve
weanling pigs.
Results on the digestive enzyme activities in the intes-
tinal mucosa and pancreatic tissue also indicated that
these are not affected by the supplementation level of
the LE ZnO or native ZnO or by the lipid percentage of
the former, although the pancreatic amylase activity was
greater in the LE-ALL vs. HIGH group. Similarly, in the
study of Hedemann et al. [28], effects of the high-ZnO
(2,500 ppm as Zn) diet on pancreatic and intestinal enzyme
activities in weanling pigs were inconclusive or equivocal.
Conclusions
The present results indicated that neither the high-ZnO
supplementation nor the physiolgical supplementation of
the LE ZnO containing 8 to 12% lipid to 100 or 250 ppm
Zn has any significant effect on growth performance, fecal
consistency, villus morphology, or digestive enzyme activ-
ities of the piglets under the experimental conditions. More
studies are necessary, however, to determine the effects of
the LE ZnO relative to those of native ZnO on these mea-
sures in weanling pigs under production conditions.
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